Analysts have been eager to weigh in on the Technology sector with new ratings on Celestica (CLS – Research Report), Meta Platforms (FB – Research Report) and PTC (PTC – Research Report).
Celestica (CLS)
In a report issued on April 28, Paul Treiber from RBC Capital maintained a Hold rating on Celestica, with a price target of $13.00. The company’s shares closed last Friday at $11.23.
According to TipRanks.com, Treiber is a 5-star analyst with an average return of
Celestica has an analyst consensus of Hold, with a price target consensus of $13.25, which is a 15.7% upside from current levels. In a report released yesterday, BMO Capital also maintained a Hold rating on the stock with a $13.00 price target.
See the top stocks recommended by analysts >>
Meta Platforms (FB)
In a report issued on April 28, Brad Erickson from RBC Capital maintained a Buy rating on Meta Platforms, with a price target of $240.00. The company’s shares closed last Friday at $200.47, close to its 52-week low of $169.00.
According to TipRanks.com, Erickson is a 5-star analyst with an average return of
Meta Platforms has an analyst consensus of Moderate Buy, with a price target consensus of $296.93, representing a 45.2% upside. In a report issued on April 14, Evercore ISI also maintained a Buy rating on the stock with a $350.00 price target.
PTC (PTC)
RBC Capital analyst Matthew Hedberg maintained a Buy rating on PTC on April 28 and set a price target of $130.00. The company’s shares closed last Friday at $114.21.
According to TipRanks.com, Hedberg is a 3-star analyst with an average return of
Currently, the analyst consensus on PTC is a Strong Buy with an average price target of $135.14, a 18.4% upside from current levels. In a report issued on April 19, Robert W. Baird also maintained a Buy rating on the stock with a $156.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CLS:
- Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Gilead Sciences (GILD) and Stryker (SYK)
- Analysts’ Opinions Are Mixed on These Financial Stocks: AFLAC (AFL), Discover Financial Services (DFS) and Getty Realty (GTY)
- Implenia AG (IPLNF) Receives a Hold from Kepler Capital
- Sanofi (SNYNF) Gets a Buy Rating from Kepler Capital
- Analysts Conflicted on These Technology Names: Materialise (MTLS), Dassault Systemes SA (OtherDASTY) and cyan AG (OtherCCYNF)
